REQUEST A DEMO
Total
USD $0.00
Search more companies

Mercury Drug Corporation (Philippines)

Main Activities: Pharmacies and Drug Stores
Full name: Mercury Drug Corporation Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Mercury Drug Corporation is an enterprise in Philippines, with the main office in Quezon City. The company operates in the Pharmacies and Drug Stores sector. It was established on May 20, 1968. There are currently 14,136 (2023) people employed by Mercury Drug Corporation. From the latest financial highlights, Mercury Drug Corporation reported a net sales revenue increase of 5.19% in 2024. A growth of 20.11% was recorded in its total assets. The net profit margin of Mercury Drug Corporation increased by 0.3% in 2024.

Headquarters
No. 7 Mercury Avenue Corner Cp Garcia Avenue, Bagumbayan
Quezon City; National Capital Region; Postal Code: 1110

Contact Details: Purchase the Mercury Drug Corporation report to view the information.

Basic Information
Total Employees:
Purchase the Mercury Drug Corporation report to view the information.
Financial Auditors:
Purchase the Mercury Drug Corporation report to view the information.
Incorporation Date:
May 20, 1968
Key Executives
Purchase this report to view the information.
Chairman and Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Mercury Drug Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
5.19%
Total Operating Revenue
5.19%
Operating Profit
16.76%
EBITDA
16.76%
Net Profit/Loss for the Period
11.86%
Total Assets
20.11%
Total Equity
-5.03%
Operating Profit Margin
0.67%
Net Profit Margin
0.3%
Return on Equity (ROE)
16%
Debt / Equity
19.98%
Quick Ratio
0.02%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?